WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2020> 31> 1

Volume: 31 Issue: 1

1. The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer Page:40—
2. The 6th Biennial Meeting of the Asian Society of Gynecologic Oncology, October 10th to 12th, 2019 Page:38—
3. The basic principles of oncologic surgery during minimally invasive radical hysterectomy Page:33—
4. A significant measure of HPV vaccine effectiveness in a high-risk population in Korea prior to a National Immunization Program Page:32—
5. High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology Page:31—
6. How to predict treatment failure in frail patients with advanced epithelial ovarian cancer: strategies to personalize surgical effort Page:26—
7. Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms Page:18—
8. Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery Page:17—
9. Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers Page:10—
10. An optimized BRCA1/2 next-generation sequencing for different clinical sample types Page:9—
11. Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study Page:8—
12. Selection criteria and colpotomic approach for safe minimally invasive radical hysterectomy in early-stage cervical cancer Page:7—
13. ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience Page:6—
14. Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group Page:5—
15. Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study Page:4—
16. Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely Page:3—
17. Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study Page:2—
18. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy Page:1—
19. Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery Page:e17—
20. Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery Page:e17—
21. Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery Page:e17—
22. The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer Page:e40—
23. The 6th Biennial Meeting of the Asian Society of Gynecologic Oncology, October 10th to 12th, 2019 Page:e38—
24. The basic principles of oncologic surgery during minimally invasive radical hysterectomy Page:e33—
25. How to predict treatment failure in frail patients with advanced epithelial ovarian cancer: strategies to personalize surgical effort Page:e26—
26. Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely Page:e3—
27. A significant measure of HPV vaccine effectiveness in a high-risk population in Korea prior to a National Immunization Program Page:e32—
28. High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology Page:e31—
29. Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers Page:e10—
30. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy Page:e1—
31. Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group Page:e5—
32. Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy:a retrospective study Page:e2—
33. Selection criteria and colpotomic approach for safe minimally invasive radical hysterectomy in early-stage cervical cancer Page:e7—
34. Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms Page:e18—
35. ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience Page:e6—
36. Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study Page:e8—
37. An optimized BRCA1/2 next-generationsequencing for different clinical sample types Page:e9—
38. Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study Page:e4—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.